AURIMOD GmbH

📍 Vienna, Austria🗓 Founded 2015👥 18 employees💰 Last funded Jul 2025
Medical Device🌐 aurimod.com
Website LinkedIn
AURIMOD is a 2015 founded start-up launched by a highly experienced and interdisciplinary team from academia, medicine and engineering. We focus on product development and applied biomedical/clinical research in the field of wearable electro-medical devices for percutaneous auricular vagus nerve stimulation. We develop innovative therapies for personalized pain management based on electrical stimulation. The targeted stimulation modulates sensory fibers of the vagus nerve in the ear. This minimal-invasive pain therapy has successfully been proven its clinical efficacy and effectiveness. Auricular vagus nerve stimulation is a non-pharmacological pain treatment with sustainable effects. Our highly innovative concept of stimulation allows for an optimized and individual therapy even for otherwise treatment resistant patients.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Switzerland
1
France
1
Frequently asked questions
Who invested in AURIMOD GmbH?
AURIMOD GmbH has 2 investors on record on gritt.io and 2 late-stage investors.
When did AURIMOD GmbH last raise funding?
The most recent investment in AURIMOD GmbH recorded on gritt.io was in July 2025.
When was AURIMOD GmbH founded?
AURIMOD GmbH was founded in 2015.
What industry is AURIMOD GmbH in?
AURIMOD GmbH operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is AURIMOD GmbH based?
AURIMOD GmbH is headquartered in Vienna, Austria.